Picture EasyFairs Connect in Pharma 2023 Geneva 650x89px

Product › Details

cancer vaccine

	Next higher product group	cancer drug

Record changed: 2023-02-23

Picture Campus Berlin-Buch at BIO2023 Location of Future Innovation 650x200px

More documents for cancer vaccine

[1] Vaximm AG. (3/8/22). "Press Release: NEC OncoImmunity Acquires Vaximm’s Neoantigen Vaccine Development Assets". Oslo, Tokyo, Basel & Mannheim....
[2] Targovax ASA. (3/7/22). "Press Release: Targovax ASA and Agenus Announce Collaboration on Mutant KRAS Cancer Vaccine Adjuvanted with QS-21 STIMULON". Oslo....
[3] Vaccibody AS. (10/1/20). "Press Release: Vaccibody Enters into Worldwide License and Collaboration Agreement with Genentech, a Member of the Roche Group, to Develop Individualized Neoantigen Cancer Vaccines". Oslo....
[4] Immuneed AB. (8/30/18). "Press Release: Ultimovacs Acquires the Immunotherapy Technology Business of Immuneed AB for NOK 50 Million"....
[5] Targovax ASA. (6/11/18). "Press Release: Targovax Strengthens Focus on ONCOS Oncolytic Virus Development Program". Oslo....
[6] Bavarian Nordic A/S. (5/16/18). "Press Release: Bavarian Nordic Announces Acceptance of Abstracts and Oral Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting". Copenhagen....
[7] Bavarian Nordic A/S. (5/2/18). "Press Release: Bavarian Nordic Receives FDA Orphan Drug Designation for BN-Brachyury for the Treatment of Chordoma". Copenhagen....
[8] Bavarian Nordic A/S. (9/14/17). "Press Release: Independent Data Monitoring Committee Recommends Discontinuation of Bavarian Nordic’s Phase 3 Study of Prostvac in Metastatic Prostate Cancer". Copenhagen....
[9] Bavarian Nordic A/S. (5/10/17). "Press Release: Bavarian Nordic Announces Appointment of Dr. Tommi Kainu as Chief Business Officer". Copenhagen....
[10] Bavarian Nordic A/S. (5/4/17). "Press Release: Bavarian Nordic Announces Interim Results for the First Three Months of 2017". Copenhagen....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)